Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
Study Information
Alliance Study ID: CALGB-89903
NCT Study ID (ClinicalTrials.gov): NCT00033748
Alliance Committee: Gastrointestinal Cancer
Disease or Cancer Type: Colorectal / Colon / Rectal Cancer
Alliance Study Chair: Mitchell C. Posner, MD
Status: COMPLETED
Study Description
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells.
PURPOSE: Phase II trial to study the effectiveness of vaccine therapy in treating patients who have colorectal cancer that has spread to the liver.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information